422 related articles for article (PubMed ID: 15119993)
21. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.
Tribble DR; Sanders JW; Pang LW; Mason C; Pitarangsi C; Baqar S; Armstrong A; Hshieh P; Fox A; Maley EA; Lebron C; Faix DJ; Lawler JV; Nayak G; Lewis M; Bodhidatta L; Scott DA
Clin Infect Dis; 2007 Feb; 44(3):338-46. PubMed ID: 17205438
[TBL] [Abstract][Full Text] [Related]
22. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
Tennenberg AM; Davis NB; Wu SC; Kahn J
Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
[TBL] [Abstract][Full Text] [Related]
23. An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia.
Lin TY; Lin SM; Chen HC; Wang CJ; Wang YM; Chang ML; Wang CH; Liu CY; Lin HC; Yu CT; Hsieh LL; Kuo HP; Huang CD
Chang Gung Med J; 2007; 30(4):321-32. PubMed ID: 17939262
[TBL] [Abstract][Full Text] [Related]
24. [Treatment and course of community-acquired pneumonia caused by atypical pathogens].
Fernández Alvarez R; Suárez Toste I; Rubinos Cuadrado G; Medina Gonzálvez A; Gullón Blanco JA; González Martín I
Arch Bronconeumol; 2006 Sep; 42(9):430-3. PubMed ID: 17040657
[TBL] [Abstract][Full Text] [Related]
25. Q fever community-acquired pneumonia in a patient with Crohn's disease on immunosuppressive therapy.
Nausheen S; Cunha BA
Heart Lung; 2007; 36(4):300-3. PubMed ID: 17628200
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy and safety of pristinamycin vs amoxicillin in community acquired pneumonia in adults].
Trémolières F; Mayaud C; Mouton Y; Weber P; Dellatolas F; Caulin E
Pathol Biol (Paris); 2005; 53(8-9):503-10. PubMed ID: 16181747
[TBL] [Abstract][Full Text] [Related]
27. Oral levofloxacin in the treatment of community-acquired pneumonia.
Nicodemo AC; Lima Nicodemo E; Idrahim KY
Braz J Infect Dis; 2000 Apr; 4(2):61-6. PubMed ID: 10795070
[TBL] [Abstract][Full Text] [Related]
28. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
29. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
Tanaseanu C; Bergallo C; Teglia O; Jasovich A; Oliva ME; Dukart G; Dartois N; Cooper CA; Gandjini H; Mallick R; ;
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):329-38. PubMed ID: 18508226
[TBL] [Abstract][Full Text] [Related]
30. [Determination of serologic markers against bacterial atypical pneumonia agents in pneumonia patients].
Pinar A; Ercis S; Ulukavak T; Dursun B; Hasçelik G
Mikrobiyol Bul; 2004; 38(1-2):27-32. PubMed ID: 15293899
[TBL] [Abstract][Full Text] [Related]
31. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
[TBL] [Abstract][Full Text] [Related]
32. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
Segreti J; House HR; Siegel RE
Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
[TBL] [Abstract][Full Text] [Related]
33. Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents.
Marrie TJ
Infect Dis Clin North Am; 2004 Dec; 18(4):829-41. PubMed ID: 15555827
[TBL] [Abstract][Full Text] [Related]
34. Treatment of lower respiratory infections in outpatients with ofloxacin compared with erythromycin.
Peugeot RL; Lipsky BA; Hooton TM; Pecoraro RE
Drugs Exp Clin Res; 1991; 17(5):253-7. PubMed ID: 1756688
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides.
Blázquez Garrido RM; Espinosa Parra FJ; Alemany Francés L; Ramos Guevara RM; Sánchez-Nieto JM; Segovia Hernández M; Serrano Martínez JA; Huerta FH
Clin Infect Dis; 2005 Mar; 40(6):800-6. PubMed ID: 15736011
[TBL] [Abstract][Full Text] [Related]
36. C-reactive protein for discriminating treatment failure from slow responding pneumonia.
Ruiz-González A; Falguera M; Porcel JM; Martínez-Alonso M; Cabezas P; Geijo P; Boixeda R; Dueñas C; Armengou A; Capdevila JA; Serrano R
Eur J Intern Med; 2010 Dec; 21(6):548-52. PubMed ID: 21111942
[TBL] [Abstract][Full Text] [Related]
37. Predictors of symptom resolution in patients with community-acquired pneumonia.
Marrie TJ; Lau CY; Wheeler SL; Wong CJ; Feagan BG
Clin Infect Dis; 2000 Dec; 31(6):1362-7. PubMed ID: 11096003
[TBL] [Abstract][Full Text] [Related]
38. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.
Plouffe JF; Breiman RF; Fields BS; Herbert M; Inverso J; Knirsch C; Kolokathis A; Marrie TJ; Nicolle L; Schwartz DB
Clin Infect Dis; 2003 Dec; 37(11):1475-80. PubMed ID: 14614670
[TBL] [Abstract][Full Text] [Related]
39. Legionella, Chlamydia pneumoniae and Mycoplasma infection in patients admitted to Christchurch Hospital with pneumonia.
Chambers ST; Town GI; Neill AM; Frampton C; Murdoch DR
N Z Med J; 1999 Jun; 112(1090):222-4. PubMed ID: 10448994
[TBL] [Abstract][Full Text] [Related]
40. [Atypical infection of the respiratory tract and bronchial asthma].
Jahnz-Rózyk K; Targowski T
Pol Merkur Lekarski; 2007 Nov; 23(137):325-7. PubMed ID: 18361312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
